GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parmax Pharma Ltd (BOM:540359) » Definitions » Pretax Margin %

Parmax Pharma (BOM:540359) Pretax Margin % : -2.34% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Parmax Pharma Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Parmax Pharma's Pre-Tax Income for the three months ended in Sep. 2024 was ₹-2.2 Mil. Parmax Pharma's Revenue for the three months ended in Sep. 2024 was ₹92.8 Mil. Therefore, Parmax Pharma's pretax margin for the quarter that ended in Sep. 2024 was -2.34%.

The historical rank and industry rank for Parmax Pharma's Pretax Margin % or its related term are showing as below:

BOM:540359' s Pretax Margin % Range Over the Past 10 Years
Min: -51.17   Med: 0.82   Max: 4.61
Current: -14.61


BOM:540359's Pretax Margin % is ranked worse than
73.57% of 995 companies
in the Drug Manufacturers industry
Industry Median: 5.23 vs BOM:540359: -14.61

Parmax Pharma Pretax Margin % Historical Data

The historical data trend for Parmax Pharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parmax Pharma Pretax Margin % Chart

Parmax Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.49 4.61 1.66 0.30 -51.17

Parmax Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.64 -132.06 -31.84 0.16 -2.34

Competitive Comparison of Parmax Pharma's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Parmax Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parmax Pharma's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parmax Pharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Parmax Pharma's Pretax Margin % falls into.



Parmax Pharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Parmax Pharma's Pretax Margin for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=-56.559/110.53
=-51.17 %

Parmax Pharma's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-2.17/92.775
=-2.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parmax Pharma  (BOM:540359) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Parmax Pharma Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Parmax Pharma's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Parmax Pharma Business Description

Traded in Other Exchanges
N/A
Address
Rajkot-Gondal National Highway No. 27, Plot No. 20, Survey No. 52, Taluka Kotda Sangani, Hadamtala, Rajkot, GJ, IND, 360 311
Parmax Pharma Ltd is a pharmaceutical company. The company manufactures and sells Tablets, Capsules, Ointments, and injectables. Its products include Aripiprazole, Lamotrigine I.P., Nebivolol Hydrochloride, Indapamine USP, Voglibos, Paliperidone, Lacosamide, 2-Acetyl Benzo(B) Thiophene, Camphor Sulfonyl Chloride, 3-Methoxy Thiophene, Silodosin API, and others.

Parmax Pharma Headlines

No Headlines